En Es
Categories

Alere

Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.
Products NewsSummary
Close

News of Alere

Global Lateral Flow Assay Market to Exceed 8 Billion by 2022

08 Sep 2017
Global Lateral Flow Assay Market to Exceed 8 Billion by 2022
The global lateral flow assay market is projected to grow at a CAGR of 8.2% from USD 5.55 billion in 2017 to USD 8.24 billion by 2022, driven mainly by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care (POC) testing, and rising use of home-based lateral flow assay devices. These are the latest findings of Research and Markets, a global market research company.
Read More
Close

About Alere

Year of Establishment: 1981
Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.
FaceBook Twitter Google+ Linked in
Influenza A&B Test

Influenza A&B Test

Model: Alere i
Request Information

Description:

The Alere i rapid molecular test is created to detect and differentiate influenza A and B virus in less than 15 minutes. The design of the test does not require temperature cycling like PCR testing, and therefore can deliver accurate results more quickly.


Send A Message To This Supplier

* Required Information
* Email
To
Alere (Influenza A&B Test)
* Message

Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions